|
福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.68 (2022) >
このアイテムの引用には次の識別子を使用してください:
http://ir.fmu.ac.jp/dspace/handle/123456789/1651
|
| タイトル: | Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine |
| 著者: | Kobashi, Yurie
Shimazu, Yuzo
Kawamura, Takeshi
Nishikawa, Yoshitaka
Omata, Fumiya
Kaneko, Yudai
Kodama, Tatsuhiko
Tsubokura, Masaharu |
| 学内所属: | 放射線健康管理学講座 |
| 誌名/書名: | Fukushima Journal of Medical Science |
| 巻: | 68 |
| 号: | 1 |
| 開始ページ: | 67 |
| 終了ページ: | 70 |
| 発行日: | 2022年 |
| 抄録: | This study investigated the immune response and outcome of BNT162b2 vaccination among 12 staff at a hospital in Fukushima, Japan. Blood samples were collected from participants before their first vaccination, with subsequent sampling performed during the participants' work days for six weeks thereafter. Antibody titers peaked 6-13 days after the second vaccination (days 27-34 after the first), followed by a steady decrease. Six males had significantly lower peak antibody titers than six females (p = 0.016 with t-test); the older six (median age 53 years) had lower antibody titers than the younger six (median age 35 years) but without statistical significance (p value=0.24 with t-test). |
| 出版者: | The Fukushima Society of Medical Science |
| 出版者（異表記）: | 福島医学会 |
| 本文の言語: | eng |
| このページのURI: | http://ir.fmu.ac.jp/dspace/handle/123456789/1651 |
| 本文URL: | http://ir.fmu.ac.jp/dspace/bitstream/123456789/1651/1/FksmJMedSci_68_p67.pdf |
| ISSN: | 0016-2590
2185-4610 |
| DOI: | 10.5387/fms.2021-28 |
| PubMed番号: | 35228456 |
| 関連ページ: | https://doi.org/10.5387/fms.2021-28 |
| 権利情報: | © 2022 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license. |
| 権利情報: | https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| 出現コレクション: | Vol.68 (2022)
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|
